# EDGAR Filing Document

**Accession Number:** 0000102037
**File Stem:** 0000102037-23-000008
**Filing Date:** 2023-2
**Character Count:** 52692
**Document Hash:** cf58512b00609d305a83c11018044145
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000102037-23-000008.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0000102037-23-000008

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230208

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNIVERSAL CORP /VA/
- **CENTRAL INDEX KEY:** 0000102037
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-FARM PRODUCT RAW MATERIALS [5150]
- **IRS NUMBER:** 540414210
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-00652
- **FILM NUMBER:** 23599305

**BUSINESS ADDRESS:**
- **STREET 1:** 9201 FOREST HILL AVENUE
- **STREET 2:** STONY POINT II BUILDING
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235
- **BUSINESS PHONE:** 8043599311

**MAIL ADDRESS:**
- **STREET 1:** 9201 FOREST HILL AVENUE
- **STREET 2:** STONY POINT II BUILDING
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** UNIVERSAL LEAF TOBACCO CO INC
- **DATE OF NAME CHANGE:** 19880314

?xml version="1.0" ? xbrl-20230208

 **UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**____________________________________________**

**FORM 8-K** 

**____________________________________________**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): February 8, 2023** 

**____________________________________________**

**UNIVERSAL CORPORATION** 

**(Exact name of registrant as specified in its charter)**

**____________________________________________**

---

| | | | |
|:---|:---|:---|:---|
| **Virginia** | | **001-00652** | **54-0414210** |
| **(State or other jurisdiction of incorporation)** | | **(Commission File Number)** | **(IRS Employer Identification No.)** |
| **9201 Forest Hill Avenue,** | **Richmond,** | **Virginia** | **23235** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | | **(Zip Code)** |

---

**Registrant's telephone number, including area code**

**(804) 359-9311** 

**Not applicable**

**(Former name or former address, if changed since last report)**

**____________________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 **Securities registered pursuant to Section 12(b) of the Exchange Act:**

Title of each class Trading Symbols Name of Exchange on which registered <br> Common Stock, no par value UVV New York Stock Exchange

**Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).**

**Emerging growth company**&nbsp;&nbsp;&nbsp;&nbsp;☐

**If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐

------

**Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

&nbsp;&nbsp;&nbsp;&nbsp;Universal Corporation (the "Company") issued a press release on February 8, 2023, discussing its results for the quarter ended December 31, 2022. The press release is attached as Exhibit 99.1 and is incorporated by reference into this Item 2.02.

------

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

---

| | | |
|:---|:---|:---|
| (d) | Exhibits |  |
|  | **No.** | **Description** |
|  | 99.1 | <u>[Press release dated February](uvv-ex991x20230208xpressre.htm)[8](uvv-ex991x20230208xpressre.htm)[, 2023, announcing financial results for the quarter ended December 31, 2022.\*](uvv-ex991x20230208xpressre.htm)</u> |
|  | 101 | Interactive Data File (submitted electronically herewith).\* |
|  |  | 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document. 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document In accordance with Rule 406T of Regulation S-T, the Inline XBRL related information in Exhibit 101 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section and shall not be part of any registration or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. |
|  | 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

__________

\*Filed herewith

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | UNIVERSAL CORPORATION | UNIVERSAL CORPORATION |
| | | (Registrant) | (Registrant) |
| Date: | February 8, 2023 | By: | /s/ Preston D. Wigner |
|  |  |  | Preston D. Wigner |
|  |  |  | Vice President, General Counsel, and Secretary |

---

------

**Exhibit Index** 

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** |<br>**Document** |
| 99.1 | <u>[Press release dated February](uvv-ex991x20230208xpressre.htm)[8](uvv-ex991x20230208xpressre.htm)[, 2023, announcing financial results for the quarter ended December 31, 2022.\*](uvv-ex991x20230208xpressre.htm)</u> |
| 101 | Interactive Data File (submitted electronically herewith).\* |
|  | 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its Inline XBRL tags are embedded within the Inline XBRL document. 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document In accordance with Rule 406T of Regulation S-T, the Inline XBRL related information in Exhibit 101 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section and shall not be part of any registration or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

__________

\*Filed herewith

## Exhibit 99.1

Exhibit 99.1

![universalcorpbluea22a.jpg](universalcorpbluea22a.jpg)

P.O. Box 25099 ~ Richmond, VA 23260 ~ Phone: (804) 359-9311 ~ Fax: (804) 254-3584

**______________________________________________________________________________________________________**

P R E S S R E L E A S E

---

| | | | |
|:---|:---|:---|:---|
| CONTACT: | Candace C. Formacek | RELEASE: | 4:16 p.m. ET |
|  | Phone: (804) 359-9311 |  |  |
|  | Fax: (804) 254-3584 |  |  |
|  | Email: investor@universalleaf.com |  |  |

---

**Universal Corporation Reports Nine Month Results**

Richmond, VA February 8, 2023 / PRNEWSWIRE

**___________________________________________________________________________________**

George C. Freeman, III, Chairman, President, and Chief Executive Officer of Universal Corporation (NYSE:UVV), stated, "We are extremely pleased with our results driven by strong tobacco shipments in the nine months and quarter ended December 31, 2022, compared to the same periods in fiscal year 2022. Tobacco shipments are generally moving smoothly, and we are not seeing the logistical constraints that we saw in the prior fiscal year. Our Ingredients Operations segment also continued to positively contribute to and diversify our results in the nine months and quarter ended December 31, 2022.

"There continues to be significant demand for leaf tobacco with all types of leaf tobacco currently in an undersupply position. Short burley tobacco crops in Africa, largely due to weather conditions, have contributed to the lower leaf tobacco supply. As of December 31, 2022, our uncommitted inventory levels stood at less than 7% of our tobacco inventory, an exceptionally low level. Although it is still early, we are forecasting larger crops in several key tobacco origins in fiscal year 2024.

"In our Ingredients Operations segment, we recently have been experiencing some softening of demand for some of our ingredients products which we believe is temporary and largely due to customers adjusting their inventory levels. Some of our ingredients customers have been carrying higher inventory levels because of supply chain uncertainties. Increased costs, particularly selling, general, and administrative expenses, including costs related to the expansion of sales and product development resources and deferred compensation costs from acquisitions, reduced our results for our Ingredients Operations segment in the quarter and nine months ended December 31, 2022.

-- M O R E --

------

*Universal Corporation*

*Page 2*

"We remain excited about the long-term outlook for our ingredients businesses and continue to make significant capital investments to enhance and increase the capabilities of our plant-based ingredients platform. We are ahead of achieving some of the earlier identified operational synergies across the platform and making considerable progress on our vision for the segment. As announced on February 1, 2023, we have appointed a new director with extensive experience in the ingredients and value-added supplier space to our corporate Board of Directors to assist us as we continue to promote and expand this business.

"We successfully refinanced and expanded our bank credit facility in the quarter ended December 31, 2022, positioning us to meet our future financial needs. In line with our previous expectations, we also reduced our outstanding borrowings considerably in the three months ended December 31, 2022, as we moved beyond our peak working capital requirements for fiscal year 2023.

"Our fiscal year 2022 Sustainability Report was published in December 2022 and is available on our website, www.universalcorp.com. Sustainability is an essential pillar of our business at Universal. We are committed to disclosing our operational activities as well as our sustainability performance in a consistent and transparent manner. We are excited about our sustainability achievements and the new and updated information and disclosures contained in our 2022 Sustainability Report."

---

| | | | |
|:---|:---|:---|:---|
| **FINANCIAL HIGHLIGHTS** | | | |
| | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |<br>**Change** |
| **(in millions of dollars, except per share data)** | **2022** | **2021** | $**%** |
| **Consolidated Results** |  |  |  |
| Sales and other operating revenue | $1875.8 | $1456.6 | 29% |
| Cost of goods sold | $1540.4 | $1170.0 | 32% |
| Gross Profit Margin | 17.9% | 19.7% | -180 bps |
| Selling, general and administrative expenses | $206.8 | $175.5 | 18% |
| Restructuring and impairment costs | $— | $10.5 | (100)% |
| Operating income (as reported) | $128.7 | $103.2 | 25% |
| Adjusted operating income (non-GAAP)\* | $128.7 | $116.5 | 10% |
| Diluted earnings per share (as reported) | $2.82 | $2.44 | 16% |
| Adjusted diluted earnings per share (non-GAAP)\* | $2.80 | $2.76 | 1% |
| **Segment Results** |  |  |  |
| Tobacco operations sales and other operating revenues | $1642.7 | $1268.6 | 29% |
| Tobacco operations operating income | $119.0 | $105.6 | 13% |
| Ingredients operations sales and other operating revenues | $233.2 | $188.0 | 24% |
| Ingredient operations operating income | $9.9 | $10.6 | (7)% |

---

\*See Reconciliation of Certain Non-GAAP Financial Measures in Other Items below.

Net income for the nine months ended December 31, 2022, was $70.3 million, or $2.82 per diluted share, compared with $60.8 million, or $2.44 per diluted share, for the nine months ended December 31, 2021. Excluding certain non-recurring items detailed in Other Items below, net income and diluted earnings per share increased by $1.1 million and $0.04, respectively, for the nine months ended December 31, 2022, compared to the nine months ended December 31, 2021. Operating income of $128.7 million for the nine months ended December 31, 2022, increased by $25.5 million, compared to operating income of $103.2 million for the nine months ended December 31, 2021. Adjusted operating income, detailed in

-- M O R E --

------

*Universal Corporation*

*Page 3*

Other Items below, of $128.7 million increased by $12.2 million for the nine months ended December 31, 2022, compared to adjusted operating income of $116.5 million for the nine months ended December 31, 2021.

Net income for the quarter ended December 31, 2022, was $41.7 million, or $1.67 per diluted share, compared with $34.9 million, or $1.40 per diluted share, for the quarter ended December 31, 2021. Excluding certain non-recurring items detailed in Other Items below, net income and diluted earnings per share decreased by $3.1 million and $0.13, respectively, for the quarter ended December 31, 2022, compared to the quarter ended December 31, 2021. Operating income of $77.5 million for the quarter ended December 31, 2022, increased by $14.8 million, compared to operating income of $62.8 million for the quarter ended December 31, 2021. Adjusted operating income, detailed in Other Items below, of $77.5 million increased by $2.7 million for the third quarter of fiscal year 2023, compared to adjusted operating income of $74.9 million for the third quarter of fiscal year 2022.

Consolidated revenues increased by $419.2 million to $1.9 billion for the nine months ended December 31, 2022, compared to the same period in fiscal year 2022, on higher tobacco sales volumes and prices as well as the addition of the business acquired in October 2021 in the Ingredients Operations segment. For the quarter ended December 31, 2022, consolidated revenues were $795.0 million, an increase of $142.4 million compared to $652.6 million for the quarter ended December 31, 2021, on higher tobacco sales volumes and prices.

**TOBACCO OPERATIONS**

Operating income for the Tobacco Operations segment increased by $13.4 million to $119.0 million and by $7.3 million to $77.1 million, respectively, for the nine months and quarter ended December 31, 2022, compared to the same periods in fiscal year 2022. Tobacco Operations segment results improved primarily due to large shipments of both carryover and current crop tobacco, in the nine months and quarter ended December 31, 2022, compared to the nine months and quarter ended December 31, 2021. While sales volumes were higher for the Tobacco Operations segment in the nine months and quarter ended December 31, 2022, compared to the same periods in the prior fiscal year, gross profit and operating margins were lower due to sales mix and sales of tobaccos that were written down in prior quarters. Tobacco shipments from Brazil of both carryover and current crops were up significantly in the nine months and quarter ended December 31, 2022, compared to the nine months and quarter ended December 31, 2021. In Africa, despite some lower burley tobacco crop sizes, tobacco sales volumes were up due to earlier shipment timing in the nine months and quarter ended December 31, 2022, compared to the same periods in fiscal year 2022. Results for our oriental tobacco joint venture were down in the nine months and quarter ended December 31, 2022, compared to the same periods in the prior fiscal year, on lower sales volumes and unfavorable foreign currency comparisons. Selling, general, and administrative expenses for the Tobacco Operations segment were higher in the nine months ended December 31, 2022, compared to the nine months ended December 31, 2021, primarily due to unfavorable foreign currency comparisons, higher provisions to suppliers, and higher compensation costs. For the quarter ended December 31, 2022, selling, general, and administrative expenses for the Tobacco Operations segment were higher compared to the quarter ended December 31, 2021, largely due to higher compensation costs and larger provisions to suppliers, in part due to lower crop yields, partially offset by favorable foreign exchange comparisons. Revenues for the Tobacco Operations segment of $1.6 billion for the nine months and $724.6 million for the quarter ended December 31, 2022, were up $374.1 million and $146.6 million, respectively, compared to the same periods in the prior fiscal year, on higher sales volumes and prices.

-- M O R E --

------

*Universal Corporation*

*Page 4*

**INGREDIENTS OPERATIONS**

Operating income for the Ingredients Operations segment was $9.9 million for the nine months ended December 31, 2022, compared to $10.6 million for the nine months ended December 31, 2021. Results for the Ingredients Operations segment were down in the nine months ended December 31, 2022, compared to the same period in the prior fiscal year, as increased sales and better margins as well as the inclusion of the October 2021 purchase of Shank's Extracts, LLC ("Shank's") were offset by increased costs, mainly higher selling, general, and administrative expenses. Operating income for the Ingredients Operations segment was $0.8 million for the quarter ended December 31, 2022, compared to $3.5 million for the quarter ended December 31, 2021, on lower sales, particularly lower sales of extracts, and higher costs. Selling, general, and administrative expenses for the segment increased in the nine months and quarter ended December 31, 2022, compared to the same periods in the prior fiscal year, largely on higher compensation costs, including final deferred compensation costs from acquisitions, as well as costs related to the expansion of sales and product development capabilities of our plant-based ingredients platform. Selling, general, and administrative expenses for the segment also increased in the nine months ended December 31, 2022, compared to the same period in the prior fiscal year, on the addition of Shank's. Revenues for the Ingredients Operations segment increased by $45.1 million to $233.2 million for the nine months ended December 31, 2022, compared to the nine months ended December 31, 2021, largely on the addition of the revenues for the acquired business as well as higher sales volumes and prices for the existing businesses. For the quarter ended December 31, 2022, revenues for the Ingredients Operations segment decreased by $4.2 million to $70.5 million, compared to the quarter ended December 31, 2021, on lower sales volumes.

**OTHER ITEMS**

Cost of goods sold in the nine months and quarter ended December 31, 2022, increased by 32% and 25% to $1.5 billion and $649.5 million, respectively, compared to the same periods in the prior fiscal year, as a result of higher raw material costs. The percentage increases in cost of goods sold were higher than comparable percentage increases in revenues in the same periods primarily due to some lower margin sales in the Tobacco Operations segment. Selling, general, and administrative costs for the nine months ended December 31, 2022, increased by $31.3 million to $206.8 million compared to the same period in the prior fiscal year, on higher compensation costs, additional costs from the acquisition of Shank's in the Ingredients Operations segment as well as unfavorable foreign currency comparisons. Selling, general, and administrative costs for the quarter ended December 31, 2022, increased by $7.7 million to $68.0 million compared to the same period in the prior fiscal year, on higher compensation costs, including final deferred compensation costs from acquisitions, and higher provisions to suppliers partially offset by favorable foreign currency comparisons. Unfavorable foreign currency comparisons were approximately $3.8 million in the nine months ended December 31, 2022, and favorable foreign currency comparisons were approximately $4.5 million in the quarter ended December 31, 2022, compared to the same periods in the prior year. Interest expense for the nine months and quarter ended December 31, 2022, increased by $12.5 million to $33.3 million and by $6.8 million to $14.3 million, respectively, largely on higher debt balances and interest rates.

For the nine months and quarter ended December 31, 2022, our effective tax rate on pre-tax income was 23.2% and 19.3%, respectively. In the nine months ended December 31, 2022, we sold our idled Tanzania operations and recognized $1.1 million of income taxes. Without this item, the consolidated effective income tax rate for the nine months ended December 31, 2022, would have been approximately 22.0%. Additionally, the sale of our idled Tanzania operations resulted in a $1.8 million reduction to consolidated interest expense related to an uncertain tax position.

-- M O R E --

------

*Universal Corporation*

*Page 5*

For the nine months and quarter ended December 31, 2021, our effective tax rate on pre-tax income was 21.0% and 23.4% respectively. In the nine months ended December 31, 2021, the Company recognized a $1.7 million income tax benefit related to a final tax ruling at a foreign subsidiary and a $1.2 million benefit in the third fiscal quarter of 2022 due to finalizing the prior year U.S. tax return. Without these income tax benefits, the adjusted effective tax rate for the nine months and quarter ended December 31, 2021, would have been 24.3% and 25.5%, respectively.

On December 15, 2022, we entered into a new bank credit agreement that replaced our existing bank credit agreement dated December 20, 2018. The terms of the new agreement are substantially similar to the terms of the prior agreement. The new agreement established a five-year committed revolving credit facility of $530 million, a funded $275 million five-year term loan, and a funded $345 million seven-year term loan. The new revolving credit facility replaced a $430 million revolving credit facility that would have matured in December 2023 and a $225 million five-year term loan and a $295 million seven-year term loan that would have matured in December 2023 and December 2025, respectively. The financial covenants under the new revolving credit facility are substantially similar to those of the previous facility and require us to maintain certain levels of tangible net worth and leverage. Under applicable accounting guidance, a significant portion of the replacement of the term loans was accounted for as a debt modification rather than a debt extinguishment.

-- M O R E --

------

*Universal Corporation*

*Page 6*

*Reconciliation of Certain Non-GAAP Financial Measures*

The following tables set forth certain non-recurring items included in reported results to reconcile adjusted operating income to consolidated operating income and adjusted net income to net income attributable to Universal Corporation:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted Operating Income Reconciliation** | | | | |
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| *(in thousands)* | **2022** | **2021** | **2022** | **2021** |
| As Reported: Consolidated operating income | $77526 | $62773 | $128678 | $103191 |
| Purchase accounting adjustment <sup>(1)</sup> |  | 3057 |  | 3057 |
| Transaction costs for acquisitions<sup>(2)</sup> |  | 597 |  | 2310 |
| Restructuring and impairment costs<sup>(3)</sup> |  | 8433 |  | 10457 |
| Fair value adjustment to contingent consideration for FruitSmart acquisition<sup>(4)</sup> |  |  |  | (2532) |
| Adjusted operating income | $77526 | $74860 | $128678 | $116483 |
| **Adjusted Net Income and Diluted Earnings Per Share** |  |  |  |  |
| *(in thousands and reported net of income taxes)* | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| As Reported: Net income available to Universal Corporation | $41660 | $34940 | $70345 | $60807 |
| Purchase accounting adjustment <sup>(1)</sup> |  | 2415 |  | 2415 |
| Transaction costs for acquisitions<sup>(2)</sup> |  | 482 |  | 2195 |
| Restructuring and impairment costs<sup>(3)</sup> |  | 6874 |  | 7879 |
| Fair value adjustment to contingent consideration for FruitSmart acquisition<sup>(4)</sup> |  |  |  | (2532) |
| Interest income and income tax benefit on a final tax ruling at a foreign subsidiary |  |  |  | (2156) |
| Interest expense reversal on uncertain tax position and income tax from sale of operations in Tanzania |  |  | (684) |  |
| Adjusted net income available to Universal Corporation | $41660 | $44711 | $69661 | $68608 |
| As reported: Diluted earnings per share | $1.67 | $1.40 | $2.82 | $2.44 |
| As adjusted: Diluted earnings per share | $1.67 | $1.80 | $2.80 | $2.76 |

---

<sup>(1)</sup> The Company recognized an increase in cost of goods sold in the third quarter of fiscal year 2022, relating to the expensing of a fair value adjustment to inventory associated with the acquisition accounting for Shank's (effective October 4, 2021).

<sup>(2)</sup> The Company incurred selling, general, and administrative expenses for due diligence and other transaction costs associated with the acquisition of Shank's.

<sup>(3)</sup> Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income, but excluded for purposes of Adjusted operating income, Adjusted net income available to Universal Corporation, and Adjusted diluted earnings per share.

<sup>(4)</sup> The Company reversed the contingent consideration liability for the FruitSmart acquisition, as a result of certain performance metrics that did not meet the required threshold stipulated in the purchase agreement.

-- M O R E --

------

*Universal Corporation*

*Page 7*

**COVID-19 PANDEMIC IMPACT**

We continue to monitor global developments related to the coronavirus ("COVID-19" or "COVID") pandemic and have taken and continue to take steps intended to mitigate the potential risks and impacts to us. Mitigating risks from COVID to our employees and our business is critically important. We have assessed and regularly update our existing health and safety protocols, business continuity plans, and related policies and practices, and we continue to work with our suppliers to mitigate the impacts to our supply chain due to the pandemic. To date, we have not experienced a material impact to our supply chain, although we previously experienced delays resulting from COVID in certain operations, we experienced increased volatility in foreign currency exchange rates which we believe in part related to COVID uncertainties and actions taken by governments and central banks, and we experienced and continue to monitor for logistical constraints around worldwide vessel and container availability and increased costs stemming from the COVID pandemic. We remain thankful for the hard work of our employees and the continued support of our customers, growers, and other partners.

-- M O R E --

------

*Universal Corporation*

*Page 8*

**Additional information**

Amounts described as net income (loss) and earnings (loss) per diluted share in the previous discussion are attributable to Universal Corporation and exclude earnings related to non-controlling interests in subsidiaries. Adjusted operating income (loss), adjusted net income (loss) attributable to Universal Corporation, adjusted diluted earnings (loss) per share, and the total for segment operating income (loss) referred to in this discussion are non-GAAP financial measures. These measures are not financial measures calculated in accordance with GAAP and should not be considered as substitutes for operating income (loss), net income (loss) attributable to Universal Corporation, diluted earnings (loss) per share, cash from operating activities or any other operating or financial performance measure calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. A reconciliation of adjusted operating income (loss) to consolidated operating (income), adjusted net income (loss) attributable to Universal Corporation to consolidated net income (loss) attributable to Universal Corporation and adjusted diluted earnings (loss) per share to diluted earnings (loss) per share are provided in Other Items above. In addition, we have provided a reconciliation of the total for segment operating income (loss) to consolidated operating income (loss) in Note 3 "Segment Information" to the consolidated financial statements. Management evaluates the consolidated Company and segment performance excluding certain significant charges or credits. We believe these non-GAAP financial measures, which exclude items that we believe are not indicative of our core operating results, provide investors with important information that is useful in understanding our business results and trends.

This release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The Company cautions readers that any statements contained herein regarding financial condition, results of operation, and future business plans, operations, opportunities, and prospects for its performance are forward-looking statements based upon management's current knowledge and assumptions about future events, and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, impacts of the ongoing COVID-19 pandemic and new subvariants; success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results; product purchased not meeting quality and quantity requirements; our reliance on a few large customers; its ability to maintain effective information technology systems and safeguard confidential information; anticipated levels of demand for and supply of its products and services; costs incurred in providing these products and services including increased transportation costs and delays attributed to global supply chain challenges; timing of shipments to customers; higher inflation rates; changes in market structure; government regulation and other stakeholder expectations; economic and political conditions in the countries in which we and our customers operate, including the ongoing impacts from the conflict in Ukraine; product taxation; industry consolidation and evolution; changes in exchange rates and interest rates; impacts of regulation and litigation on its customers; industry-specific risks related to its plant-based ingredient businesses; exposure to certain regulatory and financial risks related to climate change; changes in estimates and assumptions underlying its critical accounting policies; the promulgation and adoption of new accounting standards, new government regulations and interpretation of existing standards and regulations; and general economic, political, market, and weather conditions. Actual results, therefore, could vary from those expected. A further list and description of these risks, uncertainties, and other factors can be found in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, and in other documents the Company files with the Securities and Exchange Commission. This information should be read in conjunction with the Annual Report on Form 10-K for the year ended March 31, 2022. The Company cautions investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and it undertakes no obligation to update any forward-looking statements made.

At 5:00 p.m. (Eastern Time) on February 8, 2023, the Company will host a conference call to discuss these results. Those wishing to listen to the call may do so by visiting www.universalcorp.com at that time. A replay of the webcast will be available at that site through May 8, 2023. A taped replay of the call will be available through February 21, 2023, by dialing (866) 813-9403. The confirmation number to access the replay is 778598.

-- M O R E --

------

*Universal Corporation*

*Page 9*

Universal Corporation (NYSE: UVV), headquartered in Richmond, Virginia, is a global business-to-business agri-products supplier to consumer product manufacturers, operating in over 30 countries on five continents. We strive to be the supplier of choice for our customers by leveraging our farmer base, our commitment to a sustainable supply chain, and our ability to provide high-quality, customized, traceable, value-added agri-products essential for our customers' requirements. We find innovative solutions to serve our customers and have been meeting their agri-product needs for more than 100 years. Our principal focus since our founding in 1918 has been tobacco, and we are the leading global leaf tobacco supplier. Through our plant-based ingredients platform, we provide a variety of value-added manufacturing processes to produce high-quality, specialty vegetable- and fruit-based ingredients as well as botanical extracts and flavorings for the food and beverage end markets. For more information, visit www.universalcorp.com.

-- M O R E --

------

*Universal Corporation*

*Page 10*

**UNIVERSAL CORPORATION**

**CONSOLIDATED STATEMENTS OF INCOME** 

**(in thousands of dollars, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Sales and other operating revenues | $795039 | $652644 | $1875845 | $1456628 |
| Costs and expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of goods sold | 649539 | 521171 | 1540368 | 1169999 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 67974 | 60267 | 206799 | 175513 |
| &nbsp;&nbsp;&nbsp;Other income |  |  |  | (2532) |
| &nbsp;&nbsp;&nbsp;Restructuring and impairment costs |  | 8433 |  | 10457 |
| Operating income | 77526 | 62773 | 128678 | 103191 |
| &nbsp;&nbsp;&nbsp;Equity in pretax earnings (loss) of unconsolidated affiliates | 345 | 2084 | 208 | 5056 |
| &nbsp;&nbsp;&nbsp;Other non-operating income (expense) | (69) | 56 | (208) | 158 |
| &nbsp;&nbsp;&nbsp;Interest income | 77 | 209 | 407 | 799 |
| &nbsp;&nbsp;&nbsp;Interest expense | 14265 | 7462 | 33259 | 20800 |
| Income before income taxes and other items | 63614 | 57660 | 95826 | 88404 |
| &nbsp;&nbsp;&nbsp;Income taxes | 12253 | 13505 | 22258 | 18582 |
| Net income | 51361 | 44155 | 73568 | 69822 |
| Less: net loss (income) attributable to noncontrolling interests in subsidiaries | (9701) | (9215) | (3223) | (9015) |
| **Net income attributable to Universal Corporation** | $**41660** | $**34940** | $**70345** | $**60807** |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;Basic | $1.68 | $1.41 | $2.84 | $2.46 |
| &nbsp;&nbsp;Diluted | $1.67 | $1.40 | $2.82 | $2.44 |

---

See accompanying notes.

-- M O R E --

------

*Universal Corporation*

*Page 11*

**UNIVERSAL CORPORATION**

**CONSOLIDATED BALANCE SHEETS**

**(in thousands of dollars)**

---

| | | | |
|:---|:---|:---|:---|
| | **December 31,**<br>**2022** | **December 31,**<br>**2021** | **March 31,**<br>**2022** |
| | **(Unaudited)** | **(Unaudited)** | |
| **ASSETS** |  |  |  |
| Current assets |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $71283 | $99305 | $81648 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 536650 | 400132 | 385437 |
| &nbsp;&nbsp;&nbsp;Advances to suppliers, net | 163237 | 126830 | 129838 |
| &nbsp;&nbsp;&nbsp;Accounts receivable—unconsolidated affiliates | 5920 | 1909 | 4540 |
| &nbsp;&nbsp;&nbsp;Inventories—at lower of cost or net realizable value: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Tobacco | 866380 | 855587 | 822513 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 211561 | 161704 | 194161 |
| &nbsp;&nbsp;&nbsp;Prepaid income taxes | 17363 | 23590 | 13095 |
| &nbsp;&nbsp;&nbsp;Other current assets | 79495 | 76255 | 116779 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 1951889 | 1745312 | 1748011 |
| Property, plant and equipment |  |  |  |
| &nbsp;&nbsp;&nbsp;Land | 24142 | 24752 | 23959 |
| &nbsp;&nbsp;&nbsp;Buildings | 305215 | 296642 | 293935 |
| &nbsp;&nbsp;&nbsp;Machinery and equipment | 679970 | 662504 | 668451 |
|  | 1009327 | 983898 | 986345 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less accumulated depreciation | (663333) | (636042) | (641227) |
|  | 345994 | 347856 | 345118 |
| Other assets |  |  |  |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 42337 | 34139 | 40243 |
| &nbsp;&nbsp;&nbsp;Goodwill, net | 213881 | 214023 | 213998 |
| &nbsp;&nbsp;&nbsp;Other intangibles, net | 82917 | 95790 | 92571 |
| &nbsp;&nbsp;&nbsp;Investments in unconsolidated affiliates | 72565 | 81040 | 81006 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 10005 | 15676 | 11616 |
| &nbsp;&nbsp;&nbsp;Pension asset | 12740 | 13495 | 12667 |
| &nbsp;&nbsp;&nbsp;Other noncurrent assets | 32575 | 46197 | 41115 |
|  | 467020 | 500360 | 493216 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2764903 | $2593528 | $2586345 |

---

See accompanying notes.

-- M O R E --

------

*Universal Corporation*

*Page 12*

**UNIVERSAL CORPORATION**

**CONSOLIDATED BALANCE SHEETS**

**(in thousands of dollars)**

---

| | | | |
|:---|:---|:---|:---|
| | **December 31,**<br>**2022** | **December 31,**<br>**2021** | **March 31,**<br>**2022** |
| | **(Unaudited)** | **(Unaudited)** | |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |  |
| Current liabilities |  |  |  |
| &nbsp;&nbsp;&nbsp;Notes payable and overdrafts | $348073 | $252609 | $182639 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 208187 | 221374 | 272042 |
| &nbsp;&nbsp;&nbsp;Accounts payable—unconsolidated affiliates | 57 | 8788 | 5308 |
| &nbsp;&nbsp;&nbsp;Customer advances and deposits | 5365 | 26341 | 13724 |
| &nbsp;&nbsp;&nbsp;Accrued compensation | 21670 | 18803 | 27281 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 3715 | 10742 | 7427 |
| &nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 11160 | 9128 | 10303 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 598227 | 547785 | 518724 |
| Long-term debt | 616750 | 518547 | 518547 |
| Pensions and other postretirement benefits | 50773 | 52624 | 52890 |
| Long-term operating lease liabilities | 27030 | 22612 | 29617 |
| Other long-term liabilities | 22797 | 49235 | 34464 |
| Deferred income taxes | 48584 | 43483 | 47334 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1364161 | 1234286 | 1201576 |
| Shareholders' equity |  |  |  |
| &nbsp;&nbsp;&nbsp;Universal Corporation: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, no par value, 100,000,000 shares authorized 24,555,361 shares issued and outstanding at December 31, 2022 (24,607,384 at December 31, 2021 and 24,550,019 at March 31, 2022) | 335160 | 330306 | 330662 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 1102887 | 1090110 | 1094192 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (77255) | (104412) | (84311) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Universal Corporation shareholders' equity | 1360792 | 1316004 | 1340543 |
| &nbsp;&nbsp;&nbsp;Noncontrolling interests in subsidiaries | 39950 | 43238 | 44226 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 1400742 | 1359242 | 1384769 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $2764903 | $2593528 | $2586345 |

---

See accompanying notes.

-- M O R E --

------

*Universal Corporation*

*Page 13*

**UNIVERSAL CORPORATION &nbsp;&nbsp;&nbsp;&nbsp;**

**CONSOLIDATED STATEMENTS OF CASH FLOWS** 

**(in thousands of dollars)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
| | **2022** | **2021** |
| | **(Unaudited)** | **(Unaudited)** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net income | $73568 | $69822 |
| Adjustments to reconcile net income to net cash used by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 42844 | 39110 |
| &nbsp;&nbsp;&nbsp;Net provision for losses (recoveries) on advances to suppliers | 6127 | 2864 |
| &nbsp;&nbsp;&nbsp;Foreign currency remeasurement (gain) loss, net | (1335) | 6829 |
| &nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | 14600 | 1980 |
| &nbsp;&nbsp;&nbsp;Restructuring and impairment costs |  | 10457 |
| &nbsp;&nbsp;&nbsp;Restructuring payments |  | (3787) |
| &nbsp;&nbsp;&nbsp;Change in estimated fair value of contingent consideration for FruitSmart acquisition |  | (2532) |
| &nbsp;&nbsp;&nbsp;Other, net | 18632 | 1814 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net | (338286) | (178133) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided (used) by operating activities** | (183850) | (51576) |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property, plant and equipment | (39430) | (39831) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of business, net of cash held by the business | 3245 |  |
| &nbsp;&nbsp;&nbsp;Purchase of business, net of cash held by the business |  | (102462) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | 1634 | 12609 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash used by investing activities** | (34551) | (129684) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of short-term debt, net | 166109 | 151413 |
| &nbsp;&nbsp;&nbsp;Issuance of long-term debt | 123481 |  |
| &nbsp;&nbsp;&nbsp;Repayment of long-term debt | (23481) |  |
| &nbsp;&nbsp;&nbsp;Dividends paid to noncontrolling interests | (6825) | (6733) |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock | (3448) |  |
| &nbsp;&nbsp;&nbsp;Dividends paid on common stock | (57993) | (57241) |
| &nbsp;&nbsp;&nbsp;Proceeds from termination of interest rate swap agreements | 11786 |  |
| &nbsp;&nbsp;&nbsp;Debt issuance and other | (6337) | (3264) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided (used) by financing activities** | 203292 | 84175 |
| Effect of exchange rate changes on cash, restricted cash and cash equivalents | (1256) | (831) |
| Net decrease in cash, restricted cash and cash equivalents | (16365) | (97916) |
| Cash, restricted cash and cash equivalents at beginning of year | 87648 | 203221 |
| **Cash, restricted cash and cash equivalents at end of period** | $71283 | $105305 |
| **Supplemental Information:** |  |  |
| Cash and cash equivalents | $71283 | $99305 |
| Restricted cash (Other noncurrent assets) |  | 6000 |
| Total cash, restricted cash and cash equivalents | $71283 | $105305 |

---

See accompanying notes.

-- M O R E --

------

*Universal Corporation*

*Page 14*

**NOTE 1. BASIS OF PRESENTATION** 

Universal Corporation, which together with its subsidiaries is referred to herein as "Universal" or the "Company," is a global business-to-business agri-products supplier to consumer product manufacturers. The Company is the leading global leaf tobacco supplier and provides high-quality plant-based ingredients to food and beverage end markets. Because of the seasonal nature of the Company's business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022 (the "2022 Annual Report on Form 10-K").

**NOTE 2. EARNINGS PER SHARE** 

The following table sets forth the computation of basic and diluted earnings per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
|<br>**(in thousands, except share and per share data)** | **2022** | **2021** | **2022** | **2021** |
| **<u>Basic Earnings Per Share</u>** |  |  |  |  |
| **Numerator for basic earnings per share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income attributable to Universal Corporation | $41660 | $34940 | $70345 | $60807 |
| **Denominator for basic earnings per share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Weighted average shares outstanding | 24770294 | 24792108 | 24772827 | 24761290 |
| **Basic earnings per share** | $1.68 | $1.41 | $2.84 | $2.46 |
| **<u>Diluted Earnings Per Share</u>** |  |  |  |  |
| **Numerator for diluted earnings per share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to Universal Corporation | $41660 | $34940 | $70345 | $60807 |
| **Denominator for diluted earnings per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Weighted average shares outstanding | 24770294 | 24792108 | 24772827 | 24761290 |
| &nbsp;&nbsp;&nbsp;Effect of dilutive securities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee and outside director share-based awards | 158132 | 156983 | 161620 | 151354 |
| &nbsp;&nbsp;&nbsp;Denominator for diluted earnings per share | 24928426 | 24949091 | 24934447 | 24912644 |
| **Diluted earnings per share** | $1.67 | $1.40 | $2.82 | $2.44 |

---

-- M O R E --

------

*Universal Corporation*

*Page 15*

**NOTE 3. SEGMENT INFORMATION**

The Company conducts operations across two reportable operating segments, Tobacco Operations and Ingredients Operations.

The Tobacco Operations segment activities involve selecting, procuring, processing, packing, storing, shipping, and financing leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. Some of these tobacco types are also increasingly used in the manufacture of non-combustible tobacco products that are intended to provide consumers with an alternative to traditional combustible products. The Tobacco Operations segment also provides physical and chemical product testing and smoke testing for tobacco customers. A substantial portion of the Company's Tobacco Operations' revenues are derived from sales to a limited number of large, multinational cigarette and cigar manufacturers.

The Ingredients Operations segment provides its customers with a broad variety of plant-based ingredients for both human and pet consumption. The Ingredients Operations segment utilizes a variety of value-added manufacturing processes converting raw materials into a wide spectrum of fruit and vegetable juices, concentrates, dehydrated products, flavors, and botanical extracts. Customers for the Ingredients Operations segment include large multinational food and beverage companies, smaller independent manufacturers, and retail organizations. FruitSmart, Silva, and Shank's are the primary operations for the Ingredients Operations segment. FruitSmart manufactures fruit and vegetable juices, purees, concentrates, essences, fibers, seeds, seed oils, and seed powders. Silva is primarily a dehydrated product manufacturer of fruit and vegetable based flakes, dices, granules, powders, and blends. Shank's manufactures flavors and botanical extracts and also offers bottling and custom packaging for customers.

The Company currently evaluates the performance of its segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates. Operating results for the Company's reportable segments for each period presented in the consolidated statements of income and comprehensive income were as follows.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Nine Months Ended December 31,** | **Nine Months Ended December 31,** |
|<br>**(in thousands of dollars)** | **2022** | **2021** | **2022** | **2021** |
| **SALES AND OTHER OPERATING REVENUES** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Tobacco Operations | $724589 | $578002 | $1642682 | $1268610 |
| &nbsp;&nbsp;&nbsp;&nbsp; Ingredients Operations | 70450 | 74642 | 233163 | 188018 |
| Consolidated sales and other operating revenues | $795039 | $652644 | $1875845 | $1456628 |
| **OPERATING INCOME** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Tobacco Operations | $77104 | $69796 | $119010 | $105599 |
| &nbsp;&nbsp;&nbsp;&nbsp; Ingredients Operations | 767 | 3494 | 9876 | 10573 |
| Segment operating income | 77871 | 73290 | 128886 | 116172 |
| Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates <sup>(1)</sup> | (345) | (2084) | (208) | (5056) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring and impairment costs <sup>(2)</sup> |  | (8433) |  | (10457) |
| Add: Other income (loss)<sup>(3)</sup> |  |  |  | 2532 |
| Consolidated operating income | $77526 | $62773 | $128678 | $103191 |

---

<sup>(1)</sup> Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

<sup>(2)</sup> Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

<sup>(3)</sup> Other income represents the reversal of a portion of the contingent consideration liability associated with the acquisition of FruitSmart.

###